Published by Josh White on 9th April 2026
(Sharecast News) - Avacta Therapeutics said on Thursday that it had made "important milestones" in the first quarter of 2026, as the clinical-stage oncology company advanced its preCISION platform and secured additional funding to support development through key data readouts later this year.
URL: http://www.digitallook.com/dl/news/story/35842665/...